Author Archives: Dina

Having PubMed Access Issues?

Posted on by

Some of our MSK Library users have reported problems with accessing PubMed over the last week or so.  Should this happen to you, this is what we recommend you do:

  • Try a different browser.  It appears that the problem has been resolving itself best – or has not been present at all – when using Google Chrome.
  • Try clearing out your favorite browser’s cache.
  • If you get a browser error message, go back and try clicking on MSK Library’s PubMed link again…and then again. The problem appears to be random and multiple attempts may solve it.

If after trying these tips you still have trouble accessing PubMed, please contact the library at asklibrarian@mskcc.org or call 212-639-7439.

Dr. David Hyman explains precision medicine on PBS News Hour and more…

Posted on by
  • On the March 1 edition of PBS News Hour, MSK’s Dr. David Hyman explained changes in the way oncologists currently think about and treat cancers. He said that the new focus is on the genetic mutations that cause cancer rather than on the organ that the cancer originates from. Drugs are now being developed that target a particular mutation in a tumor and these may potentially be beneficial to patients regardless of the type of cancer (based on organ) that they have.
  • MSK will soon be incorporating real-time patient monitoring software, developed by PeraHealth, into its electronic health record (EHR) systems. It is believed that this new technology will result in improved communication among care team members as clinicians will be provided with an updated computed score of how a patient is doing every time new data is added to a patient’s record.
  • Dr. Margaret Polaneczky and her colleagues at Weill Cornell Medical College, along with clinicians at MSK, have created an online patient decision aid that helps women (ages 40-49) decide whether or not to get a mammogram. The website, available at http://breastscreeningdecisions.com, was inspired by the guideline reversal that occurred in 2009 when the U.S. Preventive Services Task Force released new screening recommendations for women ages 40-49.
  • MSK’s Dr. Samuel D. Kaffenberger and his colleagues presented a paper at the 2015 Genitourinary Cancers Symposium last week, during which they reported on a study where they were able to use protein expression characteristics to accurately stratify patients with clear cell renal cell carcinoma and predict their prognosis.

Icrave designing “patient centric ecosystem” for MSK’s Josie Robertson Surgery Center and more…

Posted on by
  • On February 16, Healthcare Design magazine offered a “first look” at MSK’s new fifteen-floor Josie Robertson Surgery Center building (designed by Perkins Eastman) currently being built in New York and scheduled to open in 2016. The article highlights the work of Icrave, the studio providing “experiential design and programming for the building”.
  • On February 4, the Business Insider described how IBM’s Watson computer system (that famously won Jeopardy!) is proving valuable to doctors. For cancer, MSK has helped IBM develop Watson for Oncology, a platform that helps physicians narrow down what is clinically relevant from mounds of patient data.
  • In a February 16 article in The Journal News, Dr. Chau Dang, chief of medical oncology at MSKCC’s new treatment center in West Harrison, provided insights into the promise of immunotherapy for fighting cancer.
  • On February 5, HCPLive highlighted a recent publication in the Journal of Clinical Oncology by MSK’s Dr. William Breitbart and his colleagues . Their randomized controlled study showed that Meaning-Centered Group Psychotherapy (MCGP) is  effective at reducing psychological and spiritual distress in patients with advanced cancer.